Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.

[1]  L. Hviid.  The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria , 2011, Expert review of vaccines.

[2]  D. Scherman,et al.  The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. , 2011, The Journal of infectious diseases.

[3]  R. Pleass,et al.  Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1 , 2011, Proceedings of the National Academy of Sciences.

[4]  B. Gamain,et al.  Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region , 2011, PloS one.

[5]  T. Theander,et al.  The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains , 2011, The Journal of Biological Chemistry.

[6]  B. Gamain,et al.  Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates , 2011, PloS one.

[7]  C. Lim,et al.  Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants , 2010, The Journal of Immunology.

[8]  T. Theander,et al.  Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies , 2010, Journal of molecular biology.

[9]  B. Gamain,et al.  Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA , 2010, Proceedings of the National Academy of Sciences.

[10]  T. Theander,et al.  Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA , 2009, Infection and Immunity.

[11]  P. Bigey,et al.  Generation of High-Titer Neutralizing Antibodies against Botulinum Toxins A, B, and E by DNA Electrotransfer , 2009, Infection and Immunity.

[12]  B. Gamain,et al.  Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites , 2008, Malaria Journal.

[13]  P. Deloron,et al.  Towards a vaccine against pregnancy-associated malaria. , 2008, Parasite.

[14]  B. Gamain,et al.  Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. , 2006, Microbes and infection.

[15]  C. Chitnis,et al.  Immunogenicity of Duffy Binding-Like Domains That Bind Chondroitin Sulfate A and Protection against Pregnancy-Associated Malaria , 2006, Infection and Immunity.

[16]  M. Molyneux,et al.  Transcribed var Genes Associated with Placental Malaria in MalawianWomen , 2006, Infection and Immunity.

[17]  Stephen J Rogerson,et al.  VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.

[18]  L. Hviid,et al.  Plasmodium falciparum Parasites Expressing Pregnancy-Specific Variant Surface Antigens Adhere Strongly to the Choriocarcinoma Cell Line BeWo , 2006, Infection and Immunity.

[19]  T. Theander,et al.  Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. , 2006, The Journal of infectious diseases.

[20]  Michael Lanzer,et al.  A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A , 2005, EMBO reports.

[21]  T. Theander,et al.  High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. , 2005, The Journal of infectious diseases.

[22]  B. Gamain,et al.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.

[23]  C. Menéndez,et al.  The sick placenta-the role of malaria. , 2004, Placenta.

[24]  I. Crocker,et al.  Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. , 2004, Placenta.

[25]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[26]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[27]  R. Leke,et al.  Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.

[28]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[29]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[30]  R. Coppel,et al.  An alternative to serum for cultivation of Plasmodium falciparum in vitro. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.